NASDAQ:CSBR

Champions Oncology Stock Forecast

etoro logo Buy CSBR
*Your capital is at risk
$6.23
-0.0200 (-0.320%)
At Close: Jun 23, 2026
AI Analysis AI Analysis of CSBR AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CSBR to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Tuesday for Champions Oncology
(Updated on Jun 23, 2026)

Buy or Hold candidate since Jun 15, 2026 Loss -1.74%

The Champions Oncology stock price fell by -0.320% on the last day (Tuesday, 23rd Jun 2026) from $6.25 to $6.23. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 4.45% from a day low at $6.17 to a day high of $6.44. The price has fallen in 6 of the last 10 days but is still up by 10.46% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -734 shares and in total, 4 thousand shares were bought and sold for approximately $23.93 thousand.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.31% during the next 3 months and, with a 90% probability hold a price between $6.00 and $7.27 at the end of this 3-month period.

CSBR Signals & Forecast

The Champions Oncology stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $6.48. On a fall, the stock will find some support from the long-term average at approximately $6.05. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 16, 2026, and so far it has fallen -9.45%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Champions Oncology stock

Champions Oncology finds support from accumulated volume at $6.02 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.274 between high and low, or 4.45%. For the last week the stock has had daily average volatility of 8.48%.

Our recommended stop-loss: $5.87 (-5.80%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (CSBR) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Champions Oncology to open at $6.28, and during the day (based on 14 day Average True Range), to move between $6.04 and $6.42, which gives a possible trading interval of +/-$0.374 (+/-6.19%) up or down from last closing price. If Champions Oncology takes out the full calculated possible swing range there will be an estimated 6.19% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $6.34 (1.77%) than the support at $6.02 (3.37%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Champions Oncology stock A Buy?

Champions Oncology holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.201 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $6.28 ( 0.780%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CSBR Performance

Trading levels for CSBR

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.55 5.18%
R2 6.45 3.50%
R1 6.38 2.46%
Price 6.23
S1 6.17 -0.90%
S2 6.11 -1.94%
S3 6.00 -3.62%

Accumulated Volume Support & Resistance Levels

Level Price
R3 6.88 10.43%
R2 6.42 3.05%
R1 6.34 1.77%
Price 6.23
S1 6.02 -3.37%
S2 5.81 -6.74%
S3 5.75 -7.70%

FAQ

What is the symbol for Champions Oncology Stock and on which exchange is it traded?
The symbol for Champions Oncology is CSBR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Champions Oncology Stock?
Champions Oncology holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Champions Oncology Stock?
Champions Oncology Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Champions Oncology Stock.

What's the current price of Champions Oncology Stock?
As of the end of day on the Jun 23, 2026, the price of an Champions Oncology (CSBR) share was $6.23.

What is the 52-week high and low for Champions Oncology Stock?
The 52-week high for Champions Oncology Stock is $9.63 and the 52-week low is $5.50.

What is the market capitalization of Champions Oncology Stock?
As of the Jun 23, 2026, the market capitalization of Champions Oncology is 86.793M.

When is the next earnings date for Champions Oncology?
The upcoming earnings date for Champions Oncology is Jul 16, 2026.
Click to get the best stock tips daily for free!
ABOUT CHAMPIONS ONCOLOGY
Champions Oncology
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE